3rd Quarter - Report

BROWN RUDNICK LLP for ROCHE DIAGNOSTICS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; yet to be introduced Senate proposal on Medicare competitive bidding related to diabetes testing supplies; Yet to be introduced House proposal for a regulatory framework for in-vitro clinical tests; Yet to be introduced Senate proposal for a regulatory framework for in-vitro clinical tests.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3271 (115th)

Medicare/Medicaid MMM

H.R. 3271 - Protecting Access to Diabetic Testing Supplies Act of 2017; yet to be introduced Senate proposal on Medicare competitive bidding related to diabetes testing supplies; Yet to be introduced House proposal for a regulatory framework for in-vitro clinical tests; Yet to be introduced Senate proposal for a regulatory framework for in-vitro clinical tests.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3271 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.